News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Sandison Taylor
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/13/2023 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Sold 7,203 shares
@ $1.53, valued at
$11k
|
|
09/13/2022 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Sold 18,478 shares
@ $0.6849, valued at
$12.7k
|
|
04/04/2022 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Granted 50,000 shares
@ $0 Granted 100,000 options to buy
@ $0.83, valued at
$83k
|
|
01/07/2022 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Exercised 10,000 restricted stock units
@ $0 Exercised 5,600 restricted stock units
@ $0 |
|
10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2020 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Granted 145,000 options to buy
@ $1.98, valued at
$287.1k
|
|
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2019 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Granted 65,000 options to buy
@ $2.61, valued at
$169.7k
|
|
02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2018 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Granted 70,000 options to buy
@ $4, valued at
$280k
|
|
09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/04/2017 |
4
| Sandison Taylor (Chief Medical Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns:
| Granted 55,000 options to buy
@ $7.8, valued at
$429k
|
|
|
|